Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt D. Furberg

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Current Controlled Trials in Cardiovascular Medicine|July 9, 2004
Balancing commercial and public interestsCurt D Furberg, Mark A Hall, Mary Ann Sevick
Journal of the American College of Cardiology|May 18, 2004
From knowledge to practice in chronic cardiovascular disease: a long and winding roadSumit R Majumdar, Finlay A McAlister, Curt D Furberg
Journal of Telemedicine and Telecare|May 17, 2014
A pilot test of a new tool for remote blood pressure monitoringKurt Boman, Andre Brenander, Mats Gustavsson, et al.
Postgraduate Medical Journal|March 20, 2014
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsSonal Singh, Yoon K Loke, Paul Enright, et al.
Hypertension (Dallas, Tex. : 1979)|June 21, 2006
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United StatesRandall S Stafford, Veronica Monti, Curt D Furberg, et al.
Circulation|August 6, 2008
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health studyDariush Mozaffarian, Curt D Furberg, Bruce M Psaty, et al.
Thorax|July 6, 2012
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsSonal Singh, Yoon K Loke, Paul Enright, et al.
Progress in Cardiovascular Diseases|May 11, 2015
Is the Guideline Process Replicable and, if Not, What Does This Mean?Allan Sniderman, Curt D Furberg, Peter P Toth, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Current Controlled Trials in Cardiovascular Medicine|July 9, 2004
Balancing commercial and public interestsCurt D Furberg, Mark A Hall, Mary Ann Sevick
Journal of the American College of Cardiology|May 18, 2004
From knowledge to practice in chronic cardiovascular disease: a long and winding roadSumit R Majumdar, Finlay A McAlister, Curt D Furberg
Journal of Telemedicine and Telecare|May 17, 2014
A pilot test of a new tool for remote blood pressure monitoringKurt Boman, Andre Brenander, Mats Gustavsson, et al.
Postgraduate Medical Journal|March 20, 2014
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsSonal Singh, Yoon K Loke, Paul Enright, et al.
Hypertension (Dallas, Tex. : 1979)|June 21, 2006
Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United StatesRandall S Stafford, Veronica Monti, Curt D Furberg, et al.
Circulation|August 6, 2008
Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health studyDariush Mozaffarian, Curt D Furberg, Bruce M Psaty, et al.
Thorax|July 6, 2012
Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medicationsSonal Singh, Yoon K Loke, Paul Enright, et al.
Progress in Cardiovascular Diseases|May 11, 2015
Is the Guideline Process Replicable and, if Not, What Does This Mean?Allan Sniderman, Curt D Furberg, Peter P Toth, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.
Pageof 11